ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q3 2017. The put-call ratio across all filers is 4.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,000 | +15.4% | 499 | 0.0% | 0.02% | +26.3% |
| Q1 2017 | $13,000 | 0.0% | 499 | 0.0% | 0.02% | -13.6% |
| Q4 2016 | $13,000 | -27.8% | 499 | 0.0% | 0.02% | -31.2% |
| Q3 2016 | $18,000 | +5.9% | 499 | 0.0% | 0.03% | +18.5% |
| Q2 2016 | $17,000 | +30.8% | 499 | 0.0% | 0.03% | +42.1% |
| Q1 2016 | $13,000 | -48.0% | 499 | -2.5% | 0.02% | -45.7% |
| Q4 2015 | $25,000 | +150.0% | 512 | +25.5% | 0.04% | +150.0% |
| Q3 2015 | $10,000 | -33.3% | 408 | -12.6% | 0.01% | -17.6% |
| Q2 2015 | $15,000 | – | 467 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |